TORONTO–( BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced its successful uplisting from the OTC Pink Sheets to the OTCQB® Venture Market (the “OTCQB”). Cybin will commence trading on the OTCQB with the market open on March 8, 2021, under the symbol “CLXPF”. The OTCQB…


Previous articleRed Light Holland’s iMicro Digital Care App Launches Virtual Telecounseling with a Membership Program Led by Certified Therapist and Microdosing Expert
Next articleMINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury